2025–2026 Regular Session · House of Representatives bill

HB 1945

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Out of committee Last action April 27, 2026: Laid on the table

Official bill page and text: palegis.us

Sponsors 13

Prime sponsor

Paul Friel

Cosponsors (12)

Ben Waxman, Benjamin Sanchez, Carol Hill-Evans, Dan Williams, Ed Neilson, Emily Kinkead, John Inglis Iii, Kristine Howard, La'Tasha Mayes, Liz Hanbidge, Tarik Khan, Valerie Gaydos

Status

Out of committee as of April 27, 2026. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 1

April 27, 2026House of RepresentativesCommittee vote (Judiciary): Report Bill As CommittedPassed26–0

yes (26) Aerion Abney, Andre Carroll, Andrew Kuzma, Benjamin Sanchez, Brenda Pugh, Charity Krupa, Chris Pielli, Christopher Rabb, Emily Kinkead, Jim Rigby, Joe Hamm, Joe Kerwin, Joseph Hohenstein, Joshua Kail, Kate Klunk, Kristine Howard, Kyle Donahue, La'Tasha Mayes, Liz Hanbidge, Malcolm Kenyatta, Melissa Shusterman, Rob Kauffman, Robert Leadbeter, Stephanie Borowicz, Tim Briggs, Timothy Bonner

Official roll call

Timeline 4

Date	Chamber	Action
April 27, 2026	House	Laid on the table
April 27, 2026	House	First consideration
April 27, 2026	House	Reported as committed
October 16, 2025	House	Referred to Judiciary

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.